Bayer CropScience Limited (NSE:BAYERCROP)
| Market Cap | 202.07B |
| Revenue (ttm) | 55.72B |
| Net Income (ttm) | 6.09B |
| Shares Out | n/a |
| EPS (ttm) | 135.49 |
| PE Ratio | 33.19 |
| Forward PE | 29.01 |
| Dividend | 125.00 (2.77%) |
| Ex-Dividend Date | Nov 14, 2025 |
| Volume | 25,290 |
| Average Volume | 44,906 |
| Open | 4,506.00 |
| Previous Close | 4,506.00 |
| Day's Range | 4,467.30 - 4,537.00 |
| 52-Week Range | 4,217.45 - 6,511.00 |
| Beta | 0.34 |
| RSI | 35.80 |
| Earnings Date | Nov 7, 2025 |
About Bayer CropScience
Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and hybrid corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well a... [Read more]
Financial Performance
In 2024, Bayer CropScience's revenue was 54.73 billion, an increase of 7.19% compared to the previous year's 51.06 billion. Earnings were 5.68 billion, a decrease of -23.30%.
Financial StatementsNews
ISARC hosts delegations to explore collab
Varanasi: The International Rice Research Institute's South Asia Regional Centre (ISARC)here hosted two high-level delegations from Bayer CropScience .
Bayer CropScience share price: HSBC upgrades to buy with Rs 5,200 target price as margin recovery takes hold
HSBC has upgraded Bayer CropScience to a buy rating and raised its target price to ₹5,200 per share, citing expectations...
Bayer CropScience share price jumps over 9% as Q4 EBITDA rises 75.4% YoY to Rs 170.8 crore
Shares of Bayer CropScience surged more than 9% in morning trade following the announcement of robust financial results for the fourth quarter of the financial year 2024-25. As of 9:16 AM, the shares ...
Bayer CropScience shares fall over 7% after Q3 net profit plunges 63%
Shares of Bayer CropScience Limited fell 7.49% to ₹4,429.30 on Tuesday after the company reported a 63.3% year-on-year (YoY) decline in net profit for Q3 FY25, despite a 10.7% YoY increase in revenue....
Bayer CropScience CFO Simon Johannes Britsch resigns, Vinit Rajesh Jindal appointed as successor
Mr. Vinit Jindal has been associated with Bayer since 2001 and has held multiple leadership positions across finance, supply chain, and strategy.
Bayer CropScience Q3 FY25 results: Net profit down 63.3% YoY to Rs 34.2 crore, revenue up 10.7%
Cost of materials consumed is ₹691.3 crore in Q3 FY25, significantly higher than ₹363.9 crore in Q3 FY24, impacting profitability.
Corporate Earnings to Watch on February 11: Lupin, Vodafone Idea, Berger Paints, IRCTC, SAIL, and More
Several companies across pharmaceuticals, telecom, infrastructure, real estate, and consumer goods are set to release their quarterly earnings on February 11, 2025. Investors will closely track these ...
This ₹6,200+ stock drops 1.5% today – what’s behind the decline?
BAYERCROP is a leading agricultural company specializing in crop protection and seeds. The company focuses on providing innovative solutions to enhance agricultural productivity and sustainability, ca...